Clinical Trial Update: Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the renal effects of levosimendan in patients with acute decompensated heart failure; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Insufficiency

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Heart Failure, Renal Insufficiency | Phase 4 | Status: UNKNOWN